These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17668882)

  • 21. Frequency and nature of the variant syndromes of autoimmune liver disease.
    Czaja AJ
    Hepatology; 1998 Aug; 28(2):360-5. PubMed ID: 9695997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis.
    Junge N; Tiedau M; Verboom M; Hallensleben M; Blasczyk R; Schlue J; Goldschmidt I; Pfister ED; Baumann U
    Eur J Pediatr; 2016 Apr; 175(4):527-37. PubMed ID: 26567543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review.
    Wang Z; Sheng L; Yang Y; Yang F; Xiao X; Hua J; Guo C; Wei Y; Tang R; Miao Q; Zhang J; Li Y; Fang J; Qiu D; Krawitt EL; Bowlus CL; Gershwin ME; Wang Q; Ma X
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):424-435. PubMed ID: 27515672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis.
    Montano-Loza A; Czaja AJ; Carpenter HA; Piette A; Murphy D; Shums Z; Burlingame R; Norman GL
    Autoimmunity; 2006 Jun; 39(4):341-8. PubMed ID: 16891223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases.
    Miyake Y; Iwasaki Y; Terada R; Onishi T; Okamoto R; Sakai N; Sakaguchi K; Shiratori Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1347-53. PubMed ID: 16629940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Takaki A; Kobashi H; Sakaguchi K; Shiratori Y
    Intern Med; 2007; 46(24):1945-9. PubMed ID: 18084114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis.
    Czaja AJ; Carpenter HA
    J Hepatol; 2004 Apr; 40(4):646-52. PubMed ID: 15030981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent autoimmune hepatitis after orthotopic liver transplantation.
    González-Koch A; Czaja AJ; Carpenter HA; Roberts SK; Charlton MR; Porayko MK; Rosen CB; Wiesner RH
    Liver Transpl; 2001 Apr; 7(4):302-10. PubMed ID: 11303289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current therapy for autoimmune hepatitis.
    Montano Loza AJ; Czaja AJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Apr; 4(4):202-14. PubMed ID: 17404588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2.
    Bittencourt PL; Goldberg AC; Cançado EL; Porta G; Carrilho FJ; Farias AQ; Palacios SA; Chiarella JM; Abrantes-Lemos CP; Baggio VL; Laudanna AA; Kalil J
    Am J Gastroenterol; 1999 Jul; 94(7):1906-13. PubMed ID: 10406258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis.
    Czaja AJ; Morshed SA; Parveen S; Nishioka M
    Hepatology; 1997 Sep; 26(3):567-72. PubMed ID: 9303484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2008 Aug; 103(8):1944-51. PubMed ID: 18564111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C.
    Brandhagen DJ; Gross JB; Poterucha JJ; Germer JJ; Czaja AJ; Smith CI; Ribeiro AC; Guerrero RB; Therneau TM; Schiff E; Gordon FD; Wiesner RH; Persing DH
    Am J Gastroenterol; 2000 Aug; 95(8):2056-60. PubMed ID: 10950057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis.
    Czaja AJ; Carpenter HA
    Hepatology; 2004 Jun; 39(6):1631-8. PubMed ID: 15185304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DRB1*010101 allele is closely associated with poor virological response to lamivudine therapy in patients with chronic hepatitis B.
    Jin YJ; Shim JH; Chung YH; Kim JA; Choi JG; Park WH; Lee D; Kim SE; Lee YS; Kim SH; Yang SH
    Digestion; 2011; 84 Suppl 1():35-42. PubMed ID: 22156484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.
    Granito A; Muratori L; Pappas G; Muratori P; Ferri S; Cassani F; Lenzi M; Bianchi FB
    Aliment Pharmacol Ther; 2005 May; 21(10):1273-7. PubMed ID: 15882249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.